A detailed history of Bahl & Gaynor Inc transactions in Aptargroup, Inc. stock. As of the latest transaction made, Bahl & Gaynor Inc holds 21,133 shares of ATR stock, worth $3.34 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,133
Previous 20,191 4.67%
Holding current value
$3.34 Million
Previous $2.84 Million 18.99%
% of portfolio
0.02%
Previous 0.02%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$138.54 - $160.11 $130,504 - $150,823
942 Added 4.67%
21,133 $3.38 Million
Q2 2024

Aug 07, 2024

SELL
$137.2 - $150.79 $34,300 - $37,697
-250 Reduced 1.22%
20,191 $2.84 Million
Q1 2024

May 10, 2024

SELL
$122.88 - $144.66 $6,144 - $7,233
-50 Reduced 0.24%
20,441 $2.94 Million
Q4 2023

Feb 02, 2024

SELL
$121.17 - $128.59 $36,351 - $38,577
-300 Reduced 1.44%
20,491 $2.53 Million
Q3 2023

Nov 03, 2023

SELL
$112.47 - $132.89 $5,286 - $6,245
-47 Reduced 0.23%
20,791 $2.6 Million
Q2 2023

Aug 14, 2023

SELL
$112.49 - $121.7 $10,124 - $10,953
-90 Reduced 0.43%
20,838 $2.41 Million
Q1 2023

May 03, 2023

SELL
$109.21 - $120.25 $5,460 - $6,012
-50 Reduced 0.24%
20,928 $2.47 Million
Q4 2022

Feb 10, 2023

SELL
$93.98 - $110.93 $86,555 - $102,166
-921 Reduced 4.21%
20,978 $2.31 Million
Q3 2022

Nov 14, 2022

SELL
$95.03 - $112.07 $9,503 - $11,207
-100 Reduced 0.45%
21,899 $2.08 Million
Q4 2021

Feb 10, 2022

SELL
$113.67 - $134.45 $16,368 - $19,360
-144 Reduced 0.65%
21,999 $2.69 Million
Q3 2021

Nov 15, 2021

SELL
$119.35 - $141.18 $175,921 - $208,099
-1,474 Reduced 6.24%
22,143 $2.64 Million
Q4 2020

Feb 02, 2021

SELL
$112.34 - $136.89 $5,617 - $6,844
-50 Reduced 0.21%
23,617 $3.23 Million
Q2 2020

Aug 13, 2020

SELL
$94.19 - $113.58 $94,190 - $113,580
-1,000 Reduced 4.05%
23,667 $2.65 Million
Q1 2020

May 26, 2020

BUY
$83.93 - $118.22 $2.07 Million - $2.92 Million
24,667 New
24,667 $2.46 Million
Q1 2020

May 15, 2020

SELL
$83.93 - $118.22 $2.12 Million - $2.99 Million
-25,277 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$116.48 - $125.92 $28,188 - $30,472
242 Added 0.97%
25,277 $2.99 Million
Q2 2019

Aug 12, 2019

SELL
$107.22 - $124.34 $57,898 - $67,143
-540 Reduced 2.11%
25,035 $3.11 Million
Q4 2018

Feb 12, 2019

BUY
$89.7 - $108.15 $32,292 - $38,934
360 Added 1.43%
25,575 $2.41 Million
Q3 2018

Nov 09, 2018

SELL
$93.29 - $111.97 $33,584 - $40,309
-360 Reduced 1.41%
25,215 $2.72 Million
Q2 2018

Aug 14, 2018

SELL
$87.93 - $96.13 $70,344 - $76,904
-800 Reduced 3.03%
25,575 $2.39 Million
Q1 2018

May 11, 2018

SELL
$81.38 - $91.83 $32,552 - $36,732
-400 Reduced 1.49%
26,375 $2.37 Million
Q3 2017

Nov 13, 2017

SELL
$80.93 - $87.08 $40,465 - $43,540
-500 Reduced 1.83%
26,775 $2.31 Million
Q2 2017

Aug 11, 2017

SELL
N/A
-230 Reduced 0.84%
27,275 $2.37 Million
Q2 2017

Aug 10, 2017

BUY
N/A
27,505
27,505 $2.02 Million

Others Institutions Holding ATR

About APTARGROUP, INC.


  • Ticker ATR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 65,337,000
  • Market Cap $10.3B
  • Description
  • AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps...
More about ATR
Track This Portfolio

Track Bahl & Gaynor Inc Portfolio

Follow Bahl & Gaynor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.